Order Article Reprints

Vater C, Mehnert E, Bretschneider H, Bolte J, Findeisen L, Matuszewski L-M, Zwingenberger S. Dose-Dependent Effects of a Novel Selective EP₄ Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model. Biomedicines. 2021; 9(11):1712. https://doi.org/10.3390/biomedicines9111712

Vater, Corina, Elisabeth Mehnert, Henriette Bretschneider, Julia Bolte, Lisa Findeisen, Lucas-Maximilian Matuszewski, and Stefan Zwingenberger. 2021. "Dose-Dependent Effects of a Novel Selective EP₄ Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model" Biomedicines 9, no. 11: 1712. https://doi.org/10.3390/biomedicines9111712

Vater, C., Mehnert, E., Bretschneider, H., Bolte, J., Findeisen, L., Matuszewski, L.-M., & Zwingenberger, S. (2021). Dose-Dependent Effects of a Novel Selective EP₄ Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model. Biomedicines, 9(11), 1712. https://doi.org/10.3390/biomedicines9111712